Jensen Peder 4
4 · FIVE PRIME THERAPEUTICS, INC. · Filed May 18, 2020
Insider Transaction Report
Form 4
Jensen Peder
Director
Transactions
- Award
Stock Option (right to buy)
2020-05-14+20,000→ 20,000 totalExercise: $4.14Exp: 2030-05-13→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option will vest in its entirety on the earlier to occur of (i) May 14, 2021 or (ii) the day before the 2021 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.